Press Releases Archives - Page 21 of 103 - Lupin

BSE 2324.25 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2324.25 NSE 2324.50

Lupin’s Joint Airways Initiative surpasses 10,000 Patients

September 28, 2023

Lupin Acquires Five Brands from Menarini

September 22, 2023

Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

September 6, 2023

Lupin Launches Propranolol Long-Acting Capsules to Improve Heart Health in Canada

August 29, 2023

Lupin Receives Approval from U.S. FDA for Pirfenidone Capsules

August 29, 2023

Lupin Receives Approval from U.S. FDA for Pirfenidone Tablets

August 25, 2023

Lupin Acquires Brands ONDERO® and ONDERO MET® to expand Diabetes Portfolio in India

August 18, 2023

Lupin Launches Tiotropium Dry Powder Inhaler for the Treatment of COPD in the United States

August 16, 2023

Lupin Launches Jeet, a Patient Support Program to Raise Awareness of Cardiovascular Disease Among Patients

August 16, 2023

Lupin Receives Approval from U.S. FDA for Metoprolol Succinate Extended-Release Tablets USP

August 16, 2023

1 2 … 20 21 22 … 102 103

Search

Hit enter to search or ESC to close